Estrogen a more powerful breast cancer culprit than we realized
May 17, 2023 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
What's New in Breast Cancer - Susan G. Komen®
Learn about new breast cancer treatment breakthroughs and recent developments in research that are fueling new ways to assess risk, prevent, detect and diagnose breast cancer.
Breast cancer deaths in the US continue to fall, but new ...
Oct 1, 2024 · The study, published Tuesday in CA: A Cancer Journal for Clinicians, found some good news: The overall breast cancer death rate in the US dropped about 44% between 1989 and 2022, which...
New study finds triple-negative breast cancer tumors with an ...
Apr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not …
Experimental immunotherapy targets metastatic breast cancer
Feb 1, 2022 · Many people with metastatic breast cancer can mount an immune reaction against their tumors, the study found, a prerequisite for this type of immunotherapy, which relies on what are called tumor-infiltrating lymphocytes (TILs).
Strongest contender in decades in fight against breast cancer
Feb 12, 2024 · FULL STORY. For decades, hormonal treatment of breast cancer has been going in one direction -- blocking estrogen. Now a global study involving researchers at the University of Adelaide has...
Breast cancer treatment: Drug Kisqali approval expanded for ...
Sep 17, 2024 · The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said. The drug was found to reduce the risk of a patient's...
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
Jun 7, 2022 · Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival. For some patients with metastatic tumors not significantly affected by other forms of chemotherapy, the treatment halted their...
WHO launches new roadmap on breast cancer
Feb 3, 2023 · The World Health Organization (WHO) released a new Global Breast Cancer Initiative Framework today providing a roadmap to attain the targets to save 2.5 million lives from breast cancer by 2040.
Enhertu Effective in HER2-Positive Metastatic Breast Cancer
Oct 19, 2021 · In people with metastatic HER2-positive breast cancer, the targeted drug trastuzumab deruxtecan (Enhertu) markedly lengthened progression-free survival compared with trastuzumab emtansine (Kadcycla), new study results show.